Skip to main content
. 2024 Nov 26;16(11):7787–7796. doi: 10.21037/jtd-24-1394

Figure 1.

Figure 1

Differences in treatment approaches for LS-SCCE between China and the United States. Percentages of different treatments for LS-SCCE in China (A) and the United States (B); survival curves for LS-SCCE patients in China (C) and the United States (D). LS-SCCE, limited-stage small cell carcinoma of the esophagus; SEER, Surveillance, Epidemiology, and End Results; S, upfront surgery; NCT, neoadjuvant chemotherapy; CRT, chemoradiotherapy; CT, chemotherapy; RT, radiotherapy; NAT, neoadjuvant therapy.